Clinical Trials Browser

Neoplasms, Second Primary × Gynecologic × 90 days × Clear all

NCT06562647 2026-02-13

SY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid Tumors

Phase NA Recruiting

Ovarian Neoplasms, Neoplasms, Second Primary